Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Escalon MedicalESMC 34 Quick Ratio is 1.94 as of Mar. 2026, which is 102% above its 10-year median of 0.96. GuruFocus rates ESMC with a GF Score™ of 34/100 and a GF Value™ of $0.15 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Escalon Medical ranks better than 51.35% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Escalon Medical's quick ratio for the quarter that ended in Mar. 2026 was 1.94.
Escalon Medical has a quick ratio of 1.94. It generally indicates good short-term financial strength.
The historical rank and industry rank for Escalon Medical's Quick Ratio or its related term are showing as below:
ESMC'
s Quick Ratio Range Over the Past 10 Years
Min: 0.61 Med: 0.96 Max: 1.94
Current: 1.94
During the past 13 years, Escalon Medical's highest Quick Ratio was 1.94. The lowest was 0.61. And the median was 0.96.
ESMC's Quick Ratio is ranked better than 51.35% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 1.89
vs ESMC: 1.94
Escalon Medical (OTCPK:ESMC) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Escalon Medical Quick Ratio Related Terms
Escalon Medical Quick Ratio Historical Data
* Premium members only.
The historical data trend for Escalon Medical's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Escalon Medical's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Escalon Medical Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Escalon Medical's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Escalon Medical's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Escalon Medical's Quick Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Escalon Medical (ESMC) has a Quick Ratio of 1.94 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Escalon Medical and its competitors. This is 102% above median its historical median of 0.96. Over the past decade, Escalon Medical's Quick Ratio has ranged from 0.61 to 1.94. According to the industry distribution chart, Escalon Medical ranks #415 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 48.7%.
Is Escalon Medical's Quick Ratio too high?
Escalon Medical's current Quick Ratio of 1.94 is 102% above median its 10-year median of 0.96. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 1.94. The Medical Devices & Instruments industry median Quick Ratio is 1.89. Escalon Medical's value of 1.94 is 2.6% above this industry median. Based on the distribution chart, Escalon Medical ranks #415 out of 853 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Escalon Medical has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Escalon Medical's Quick Ratio compare to RBOT and NUWE?
According to the Medical Devices & Instruments industry distribution chart, Escalon Medical ranks #415 out of 853 companies for Quick Ratio. This puts Escalon Medical in the upper half of its industry. The industry median Quick Ratio is 1.89. Escalon Medical's value of 1.94 is 2.6% above this benchmark. Historically, Escalon Medical's own Quick Ratio has ranged from 0.61 to 1.94 over the past decade. While the company's 10-year median is 0.96 vs. the industry median of 1.89, Escalon Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Escalon Medical's current Quick Ratio of 1.94 is 2.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Escalon Medical and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Escalon Medical's current Quick Ratio is 1.94, which is 102% above median its own 10-year median of 0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Escalon Medical stock overvalued right now?
Based on GuruFocus' analysis, Escalon Medical (ESMC) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.15, compared to a current price of $0.20 — trading 33.3% above its estimated fair value. The current Quick Ratio is 1.94, which is 102% above median its 10-year median of 0.96 and 2.6% above the Medical Devices & Instruments industry median of 1.89. Escalon Medical's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Escalon Medical (ESMC), the current Quick Ratio is 1.94 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Escalon Medical (ESMC) Overvalued in 2026?
Based on GuruFocus' analysis, Escalon Medical stock appears to be overvalued.
The current stock price of $0.20 is trading 33.3% above its estimated GF Value™ of $0.15.
GuruFocus considers Escalon Medical to be Significantly Overvalued.
Key valuation signals for ESMC:
Quick Ratio: 1.94 (102% above median its 10-year median of 0.96)
GF Value™: $0.15 vs. price of $0.20 (33.3% above fair value)
Industry Position: 2.6% above the Medical Devices & Instruments median (#415 of 853)
No single metric tells the full story. See the ESMC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Escalon Medical Corp operates in the healthcare market, specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its products are A-Scans, B-Scans, UBM, Pachymeters, Ispan Intraocular Gases, Surgical Packs, Viscous Fluid Transfer Systems, and AXIS Image Management. Substantial revenue is generated from the domestic sales of products.
34GF Score
Get the complete analysis for ESMC
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESMC has been successfully added to your 
